respiratori
viral
infect
main
caus
morbid
mortal
develop
countri
nair
et
al
walker
et
al
accur
rapid
identif
etiolog
agent
import
patient
manag
control
respiratori
diseas
outbreak
garbino
et
al
clinic
present
respiratori
infect
caus
variou
viral
pathogen
similar
henc
etiolog
diagnosi
import
coira
et
al
also
may
possibl
occur
pediatr
individu
respiratori
viral
infect
tradit
diagnos
laboratori
cultur
respiratori
specimen
direct
fluoresc
assay
dfa
ginocchio
nucleic
acid
amplif
test
naat
develop
classic
well
newli
emerg
respiratori
virus
shown
sensit
time
effici
dfa
cultur
howev
test
respiratori
viral
target
use
individu
pcr
expens
labori
convent
multiplex
would
use
tool
resourc
limit
set
therefor
multiplex
pcr
method
develop
aim
detect
differ
virus
simultan
coira
et
al
et
al
kim
et
al
choudhari
et
al
introduct
multiplex
real
time
assay
increas
effici
routin
molecular
diagnosi
respiratori
virus
shown
cost
effect
gunson
et
al
mahoni
et
al
auburn
et
al
jansen
et
al
use
specif
label
probe
ensur
easi
interpret
use
multiplex
format
howev
multiplex
may
reduc
assay
sensit
limit
due
avail
commerci
avail
fluorophor
instrument
fox
multiplex
pcr
follow
detect
product
suspens
microarray
one
promis
approach
simultan
detect
multipl
respiratori
virus
krunic
et
al
lee
et
al
mahoni
et
al
merant
et
al
pabbaraju
et
al
xtag
respiratori
viru
panel
rvp
fast
assay
luminex
molecular
diagnost
inc
toronto
canada
ce
mark
commerci
avail
kit
base
suspens
microarray
technolog
enabl
detect
larg
number
virus
singl
reaction
krunic
et
al
merant
et
al
rvp
fast
assay
simpl
protocol
shorter
turnaround
time
origin
rvp
assay
detect
differ
virus
subtyp
influenza
subtyp
influenza
b
respiratori
syncyti
viru
parainfluenza
viru
human
metapneumoviru
coronavirus
rhinovirusenteroviru
rhvev
adenoviru
human
bocaviru
recent
studi
show
rvp
assay
sensit
specif
compar
cultur
antigen
detect
wong
et
al
gadsbi
et
al
howev
major
disadvantag
rvp
fast
assay
cost
kit
instrument
studi
compar
perform
develop
convent
multiplex
monoplex
real
time
xtag
rvp
fast
assay
detect
multipl
respiratori
virus
subtyp
clinic
specimen
respiratori
specimen
nasalthroat
swab
n
mainli
pediatr
patient
less
year
age
refer
nation
institut
virolog
pune
august
march
diagnosi
influenza
includ
studi
sampl
influenza
time
collect
store
retrospect
studi
approv
institut
ethic
committe
mean
age
patient
year
studi
compris
male
femal
total
nucleic
acid
dna
rna
extract
perform
use
qiaamp
nucleic
acid
extract
kit
cat
qiagen
germani
accord
manufactur
instruct
two
hundr
microlitr
clinic
sampl
spike
intern
control
rvp
fast
assay
provid
manufactur
elut
elut
buffer
three
test
perform
parallel
convent
multiplex
monoplex
real
time
carri
describ
choudhari
et
al
carri
three
tubesset
cover
virus
subtyp
set
influenza
subtyp
season
pandem
influenza
b
set
rsv
b
hmpv
piv
set
coronaviru
coronaviru
rhinovirusenteroviru
adenoviru
bocaviru
test
real
time
monoplex
one
step
real
time
influenza
subtyp
season
pandem
influenza
b
intern
control
rnasep
carri
accord
protocol
provid
center
diseas
control
prevent
usa
cdc
b
coronaviru
rhinoviru
assay
perform
describ
gunson
et
al
hmpv
maertzdorf
et
al
describ
follow
websit
http
luminex
rvp
fast
assay
ce
certifi
kit
detect
influenza
includ
subtyp
influenza
b
rsv
b
hmpv
piv
coronaviru
rhinovirusenteroviru
adenoviru
bocaviru
rvp
fast
assay
kit
differenti
rhinoviru
enteroviru
rvp
fast
assay
kit
detect
influenza
marker
subtyp
influenza
addit
rna
bacteriophag
use
intern
extract
control
dna
bacteriophag
lambda
use
amplif
assay
perform
control
lambda
control
fail
rvp
fast
assay
test
repeat
obtain
valid
result
one
step
singl
tube
multiplex
perform
accord
xtag
rvp
fast
assay
product
insert
instruct
pcr
amplif
perform
geneamp
pcr
system
appli
biosystem
foster
citi
use
follow
cycl
paramet
preheat
step
cdna
synthesi
min
denatur
cycl
min
follow
amplif
cycl
sec
sec
sec
end
cycl
min
hold
readi
use
reagent
xtag
rvp
fast
bead
mix
report
buffer
xtag
streptavidin
phycoerythrin
conjug
vortex
use
dilut
prepar
xtag
report
buffer
hybrid
reaction
contain
bead
mix
amplifi
dna
plate
plate
incub
min
follow
analysi
luminex
instrument
use
softwar
result
analyz
softwar
true
posit
gold
standard
defin
posit
one
test
use
specimen
posit
one
test
confirm
sequenc
method
true
agreement
defin
least
one
viru
least
two
method
third
method
detect
one
viru
addit
viru
confirm
sequenc
sequenc
rsv
glycoprotein
gene
choudhari
et
al
metapneumoviru
nucleoprotein
gene
choudhari
et
al
parainfluenza
viru
hemagglutinin
gene
rhinoviru
region
coronaviru
surfac
glycoprotein
gene
sequenc
use
develop
unpublish
primer
virus
includ
ie
adenoviru
bocaviru
identifi
rvp
fast
assay
consid
discord
also
confirm
sequenc
statist
analysi
carri
use
pasw
statist
softwar
packag
sensit
specif
also
comput
three
test
thirti
five
known
influenza
posit
sampl
test
studi
subtyp
viru
accord
protocol
rvp
fast
kit
detect
influenza
marker
subtyp
influenza
rvp
fast
kit
detect
posit
influenza
fals
neg
influenza
sensit
specif
influenza
viru
ci
sensit
rvp
fast
assay
ci
five
sampl
posit
influenza
b
rvp
fast
assay
detect
one
specimen
posit
concord
observ
influenza
influenza
b
sensit
rvp
fast
assay
influenza
b
ci
total
sampl
detect
posit
rhinovirusenteroviru
rvp
fast
assay
respect
sensit
rhinovirusenteroviru
detect
ci
rvp
fast
assay
ci
ten
sampl
detect
posit
rvp
fast
assay
respect
confirm
rhinoviru
sequenc
total
sampl
posit
rhinovirusenteroviru
sequenc
region
sampl
confirm
rhinoviru
enteroviru
sequenc
sampl
detect
posit
rvp
fast
assay
detect
sensit
ci
rvp
fast
assay
ci
one
sampl
neg
posit
rvp
fast
assay
confirm
sequenc
posit
twenti
sampl
neg
rvp
fast
assay
eight
sampl
randomli
select
sequenc
confirm
sampl
detect
posit
two
rvp
fast
assay
sampl
neg
rvp
fast
assay
nine
randomli
select
sampl
confirm
posit
sequenc
concord
observ
rsv
b
two
sampl
detect
posit
one
posit
rvp
fast
assay
sampl
neg
rvp
fast
assay
confirm
posit
sequenc
total
sampl
detect
posit
respect
eight
rvp
fast
assay
sensit
ci
ci
rvp
fast
assay
ci
sampl
neg
rvp
fast
assay
nine
sampl
ware
posit
one
sampl
posit
confirm
sequenc
nine
sampl
posit
seven
sampl
posit
rvp
fast
assay
four
sampl
posit
two
sampl
neg
rvp
fast
assay
posit
confirm
sequenc
human
metapneumoviru
seven
six
five
sampl
detect
posit
rvp
fast
respect
two
sampl
neg
one
rvp
fast
assay
confirm
hmpv
posit
sequenc
coronaviru
detect
six
sampl
rvp
fast
assay
four
sampl
detect
posit
two
specimen
neg
confirm
coronaviru
posit
sequenc
adenoviru
bocaviru
includ
sensit
calcul
sinc
test
two
virus
none
sampl
found
posit
season
influenza
one
kit
xtag
rvp
fast
assay
contain
reagent
test
addit
extern
control
need
includ
run
full
plate
one
control
recommend
reagent
nucleic
acid
extract
step
purchas
separ
cost
test
virus
discuss
present
studi
one
sampl
rvp
fast
assay
us
us
us
respect
includ
reagent
cost
exclud
labor
cost
overal
durat
xtag
rvp
fast
assay
hr
sampl
includ
one
posit
one
neg
control
min
rna
extract
min
pcr
setup
min
min
hybrid
setup
min
hybrid
min
read
luminex
instrument
overal
durat
real
time
assay
hr
sampl
includ
one
posit
one
neg
control
min
rna
extract
min
pcr
setup
hr
run
thrice
one
instrument
overal
durat
assay
hr
sampl
includ
one
posit
one
neg
control
min
rna
extract
min
pcr
setup
hr
run
min
gel
run
tradit
method
detect
identif
respiratori
virus
like
cell
cultur
immunofluoresc
labor
intens
slow
depend
specimen
qualiti
nucleic
acid
amplif
test
naat
shown
increas
sensit
quicker
turnaround
time
compar
test
aren
et
al
high
detect
rate
naat
due
inclus
larger
number
viral
target
increas
sensit
allow
detect
low
copi
number
differ
virus
mahoni
et
al
pabbaraju
et
al
final
accur
diagnosi
optim
antivir
treatment
implement
infect
control
public
health
measur
respiratori
viru
panel
assay
base
suspens
microarray
technolog
enabl
detect
larg
number
target
singl
reaction
krunic
et
al
merant
et
al
rvp
fast
assay
provid
consider
reduct
time
less
step
post
pcr
manipul
first
version
assay
merant
et
al
rvp
assay
shown
offer
result
compar
superior
culturedfa
nucleic
acid
test
diagnosi
respiratori
viral
infect
mahoni
et
al
pabbaraju
et
al
jokela
et
al
xtag
rvp
assay
shown
best
sensit
common
viral
target
compar
resplex
ii
assay
compar
cultur
et
al
xtag
rvp
assay
also
use
success
detect
etiolog
agent
outbreak
respiratori
ill
wong
et
al
studi
perform
develop
convent
multiplex
monoplex
real
time
luminex
rvp
fast
assay
assess
retrospect
test
respiratori
clinic
sampl
origin
submit
diagnosi
influenza
viru
overal
sensit
rvp
fast
assay
respect
sinc
bocaviru
adenoviru
test
multiplex
real
time
henc
exclud
sensit
calcul
test
studi
found
rvp
fast
assay
less
sensit
overal
rvp
fast
assay
sensit
report
gadsbi
et
al
target
report
pabbaraju
et
al
report
kim
et
al
report
raymaek
et
al
pabbaraju
et
al
report
rvp
assay
sensit
specif
respect
naat
consid
gold
standard
anoth
studi
rvp
fast
assay
show
sensit
specif
compar
cultur
show
resplex
ii
show
respect
et
al
popowitch
et
al
report
sensit
specif
xtag
rvp
fast
respect
present
studi
lower
sensit
rvp
fast
assay
observ
compar
report
studi
may
due
fact
studi
compar
rvp
fast
assay
well
standard
robust
molecular
assay
use
clinic
sampl
wherea
studi
compar
rvp
fast
assay
cultur
dfa
use
isol
anoth
reason
may
sequenc
variat
bind
region
virus
circul
india
part
world
recent
studi
synlab
germani
http
comparison
made
homebrew
light
cycler
assay
rvp
fast
rvp
fast
extend
amplif
rvp
fast
assay
perform
well
qualiti
control
molecular
diagnost
qcmd
sampl
ct
valu
lower
howev
sampl
ct
valu
higher
consider
drop
sensit
observ
remedi
pcr
cycl
increas
cycl
extend
amplif
increas
sensit
protocol
xtag
rvp
fast
assay
modifi
present
studi
sinc
ce
mark
kit
consid
entir
detect
spectrum
present
studi
detect
sampl
posit
rvp
fast
assay
similar
find
report
previou
studi
use
rvp
fast
assay
gadsbi
et
al
babadi
et
al
origin
rvp
assay
mahoni
et
al
pabbaraju
et
al
gharabaghi
et
al
detect
rvp
fast
assay
shown
tabl
ii
similar
report
other
rvp
assay
mahoni
et
al
pabbaraju
et
al
gadsbi
et
al
jokela
et
al
rvp
fast
assay
mainli
fail
detect
influenza
b
rsv
b
virus
concord
influenza
influenza
b
rsv
b
influenza
sampl
miss
rvp
fast
assay
mfi
median
fluoresc
intens
valu
rang
cut
valu
consid
posit
influenza
target
mfi
observ
discord
result
rvp
neg
sampl
associ
rel
high
ct
valu
mean
ct
limit
xtag
rvp
fast
assay
subtyp
influenza
kit
upgrad
sinc
emerg
upgrad
xtag
rvp
fast
assay
accommod
subtyp
influenza
viru
might
increas
diagnost
valu
kit
lower
sensit
influenza
b
also
report
pabbaraju
et
al
suggest
sequenc
variat
hemagglutinin
gene
flu
b
primer
bind
region
gharabaghi
et
al
report
influenza
b
sensit
rvp
fast
assay
sensit
rvp
fast
assay
respect
gharabaghi
et
al
report
sensit
similar
report
publish
group
gadsbi
et
al
rand
et
al
kim
et
al
popowitch
et
al
low
sensit
rsv
rvp
assay
attribut
high
ct
valu
real
time
may
due
genet
variat
viru
pabbaraju
et
al
also
observ
discord
rsv
low
titer
well
lower
sensit
rvp
fast
assay
also
report
gharabaghi
et
al
babadi
et
al
hmpv
rhinoviru
detect
lower
sensit
compar
rvp
fast
assay
combin
rhinoviru
enteroviru
target
virus
club
togeth
rhvev
perform
sensit
test
real
time
sensit
rhinoviru
rvp
fast
assay
respect
reduc
sensit
may
rvp
fast
assay
detect
rhinoviru
enteroviru
specif
detect
rhinoviru
sensit
rhvev
rvp
fast
assay
report
popowitch
et
al
gadsbi
et
al
total
rhinovirusenteroviru
posit
sampl
sequenc
confirm
rhinoviru
six
enteroviru
sequenc
similar
find
also
report
other
pabbaraju
et
al
gadsbi
et
al
rel
lower
number
specimen
posit
coronavirus
parainfluenza
metapneumoviru
sampl
set
two
coronaviru
posit
sampl
miss
ct
valu
signific
limit
present
studi
absenc
influenza
evalu
kit
perform
detect
therefor
larger
number
posit
specimen
requir
order
fulli
assess
sensit
rvp
fast
assay
target
addit
sensit
specif
eas
use
requir
time
cost
import
factor
consid
choos
multiplex
pcr
assay
evalu
studi
advantag
disadvantag
cost
test
virus
discuss
present
studi
one
sampl
assay
us
us
us
respect
includ
reagent
consum
overal
durat
rvp
fast
assay
hr
real
time
hr
hr
similar
observ
workflow
cost
report
rvp
fast
assay
rand
et
al
babadi
et
al
luminex
xtag
rvp
fast
assay
advantag
strict
qualiti
control
manufactur
practic
minim
error
test
sampl
luminex
xtag
rvp
assay
open
pcr
system
post
amplif
product
manipul
hybrid
increas
risk
potenti
laboratori
contamin
kim
et
al
disadvantag
requir
visual
inspect
product
gel
potenti
amplicon
contamin
real
time
offer
decreas
contamin
risk
technic
skill
requir
perform
xtag
rvp
fast
assay
limit
present
studi
test
prospect
sampl
summari
develop
show
better
sensit
specif
cost
effect
compar
rvp
fast
assay
result
studi
indic
implement
develop
test
respiratori
sampl
improv
rate
diagnosi
respiratori
tract
infect
use
resourc
limit
set
